Sage’s Biogen-Partnered Essential Tremor Drug Fails In Phase II

Companies Discontinue Development In ET

 
• By Mandy Jackson
  
Uncontrollable hand or another parts of body. Slowness of movement or stiffness of the limbs and trunk.
The companies are evaluating indications beyond essential tremor • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D